Biologics Market Research Report by Product (Cellular Based Biologics, Gene Based Biologics, and Monoclonal Antibodies), by Application (Autoimmune Diseases, Cancer, and Infectious Diseases), by State (California, Florida, and Illinois) - United States Fo

Biologics Market Research Report by Product (Cellular Based Biologics, Gene Based Biologics, and Monoclonal Antibodies), by Application (Autoimmune Diseases, Cancer, and Infectious Diseases), by State (California, Florida, and Illinois) - United States Forecast to 2026 - Cumulative Impact of COVID-19

The United States Biologics Market size was estimated at USD 47.83 billion in 2020 and expected to reach USD 52.87 billion in 2021, at a CAGR 7.87% to reach USD 75.37 billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.


Market Segmentation & Coverage:

This research report categorizes the Biologics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies, Recombinant Hormones/Proteins, and Vaccines. The Monoclonal Antibodies is further studied across Diagnostic and Therapeutic. The Diagnostic is further studied across Biochemical Analysis and Diagnostic Imaging. The Therapeutic is further studied across Direct MAB Agents and Targeting MAB Agents.

Based on Application, the market was studied across Autoimmune Diseases, Cancer, Infectious Diseases, and Rare Diseases.

Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biologics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Biologics Market, including AbbVie Inc., Allergan, Amgen Inc, Apogenix, AstraZeneca, Bayer AG, Biocon, BioMarin Pharmaceutical, Celltrion, Eli Lilly and Company, F. Hoffmann-La Roche AG, Gangagen, GlaxoSmithKline PLC, GSK group of companies, Johnson & Johnson, Medexus Pharma, Merck & Co., Novo Nordisk AS, Pfizer Inc., Precision Biologics, Inc., Samsung BioLogics, Sanofi SA, Theratome Bio, Tubulis Technologies, and Vaximm.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Biologics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Biologics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Biologics Market?
4. What is the competitive strategic window for opportunities in the United States Biologics Market?
5. What are the technology trends and regulatory frameworks in the United States Biologics Market?
6. What is the market share of the leading vendors in the United States Biologics Market?
7. What modes and strategic moves are considered suitable for entering the United States Biologics Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Introduction
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges
6. Biologics Market, by Product
6.1. Introduction
6.2. Cellular Based Biologics
6.3. Gene Based Biologics
6.4. Monoclonal Antibodies
6.4.1. Diagnostic
6.4.1.1. Biochemical Analysis
6.4.1.2. Diagnostic Imaging
6.4.2. Therapeutic
6.4.2.1. Direct MAB Agents
6.4.2.2. Targeting MAB Agents
6.5. Recombinant Hormones/Proteins
6.6. Vaccines
7. Biologics Market, by Application
7.1. Introduction
7.2. Autoimmune Diseases
7.3. Cancer
7.4. Infectious Diseases
7.5. Rare Diseases
8. California Biologics Market
9. Florida Biologics Market
10. Illinois Biologics Market
11. New York Biologics Market
12. Ohio Biologics Market
13. Pennsylvania Biologics Market
14. Texas Biologics Market
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. AbbVie Inc.
16.2. Allergan
16.3. Amgen Inc
16.4. Apogenix
16.5. AstraZeneca
16.6. Bayer AG
16.7. Biocon
16.8. BioMarin Pharmaceutical
16.9. Celltrion
16.10. Eli Lilly and Company
16.11. F. Hoffmann-La Roche AG
16.12. Gangagen
16.13. GlaxoSmithKline PLC
16.14. GSK group of companies
16.15. Johnson & Johnson
16.16. Medexus Pharma
16.17. Merck & Co.
16.18. Novo Nordisk AS
16.19. Pfizer Inc.
16.20. Precision Biologics, Inc.
16.21. Samsung BioLogics
16.22. Sanofi SA
16.23. Theratome Bio
16.24. Tubulis Technologies
16.25. Vaximm
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES BIOLOGICS MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. UNITED STATES BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 3. UNITED STATES BIOLOGICS MARKET: MARKET DYNAMICS
FIGURE 4. UNITED STATES BIOLOGICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 5. UNITED STATES BIOLOGICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD BILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BIOLOGICS MARKET SIZE, BY PRODUCT, 2026
FIGURE 7. UNITED STATES BIOLOGICS MARKET SIZE, BY CELLULAR BASED BIOLOGICS, 2018-2026 (USD BILLION)
FIGURE 8. UNITED STATES BIOLOGICS MARKET SIZE, BY CELLULAR BASED BIOLOGICS, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 9. UNITED STATES BIOLOGICS MARKET SIZE, BY GENE BASED BIOLOGICS, 2018-2026 (USD BILLION)
FIGURE 10. UNITED STATES BIOLOGICS MARKET SIZE, BY GENE BASED BIOLOGICS, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 11. UNITED STATES BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2026 (USD BILLION)
FIGURE 12. UNITED STATES BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 13. UNITED STATES BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2026 (USD BILLION)
FIGURE 14. UNITED STATES BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 15. UNITED STATES BIOLOGICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, 2018-2026 (USD BILLION)
FIGURE 16. UNITED STATES BIOLOGICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 17. UNITED STATES BIOLOGICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2026 (USD BILLION)
FIGURE 18. UNITED STATES BIOLOGICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 19. UNITED STATES BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2026 (USD BILLION)
FIGURE 20. UNITED STATES BIOLOGICS MARKET SIZE, BY THERAPEUTIC, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 21. UNITED STATES BIOLOGICS MARKET SIZE, BY DIRECT MAB AGENTS, 2018-2026 (USD BILLION)
FIGURE 22. UNITED STATES BIOLOGICS MARKET SIZE, BY DIRECT MAB AGENTS, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 23. UNITED STATES BIOLOGICS MARKET SIZE, BY TARGETING MAB AGENTS, 2018-2026 (USD BILLION)
FIGURE 24. UNITED STATES BIOLOGICS MARKET SIZE, BY TARGETING MAB AGENTS, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 25. UNITED STATES BIOLOGICS MARKET SIZE, BY RECOMBINANT HORMONES/PROTEINS, 2018-2026 (USD BILLION)
FIGURE 26. UNITED STATES BIOLOGICS MARKET SIZE, BY RECOMBINANT HORMONES/PROTEINS, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 27. UNITED STATES BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2026 (USD BILLION)
FIGURE 28. UNITED STATES BIOLOGICS MARKET SIZE, BY VACCINES, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 29. UNITED STATES BIOLOGICS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 30. UNITED STATES BIOLOGICS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BIOLOGICS MARKET SIZE, BY APPLICATION, 2026
FIGURE 32. UNITED STATES BIOLOGICS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2026 (USD BILLION)
FIGURE 33. UNITED STATES BIOLOGICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 34. UNITED STATES BIOLOGICS MARKET SIZE, BY CANCER, 2018-2026 (USD BILLION)
FIGURE 35. UNITED STATES BIOLOGICS MARKET SIZE, BY CANCER, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 36. UNITED STATES BIOLOGICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2026 (USD BILLION)
FIGURE 37. UNITED STATES BIOLOGICS MARKET SIZE, BY INFECTIOUS DISEASES, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 38. UNITED STATES BIOLOGICS MARKET SIZE, BY RARE DISEASES, 2018-2026 (USD BILLION)
FIGURE 39. UNITED STATES BIOLOGICS MARKET SIZE, BY RARE DISEASES, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 40. UNITED STATES BIOLOGICS MARKET: FPNV POSITIONING MATRIX
FIGURE 41. UNITED STATES BIOLOGICS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 42. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES BIOLOGICS MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES BIOLOGICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. UNITED STATES BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 5. UNITED STATES BIOLOGICS MARKET SIZE, BY CELLULAR BASED BIOLOGICS, BY STATE, 2018-2026 (USD BILLION)
TABLE 6. UNITED STATES BIOLOGICS MARKET SIZE, BY GENE BASED BIOLOGICS, BY STATE, 2018-2026 (USD BILLION)
TABLE 7. UNITED STATES BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY STATE, 2018-2026 (USD BILLION)
TABLE 8. UNITED STATES BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, BY STATE, 2018-2026 (USD BILLION)
TABLE 9. UNITED STATES BIOLOGICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, BY STATE, 2018-2026 (USD BILLION)
TABLE 10. UNITED STATES BIOLOGICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY STATE, 2018-2026 (USD BILLION)
TABLE 11. UNITED STATES BIOLOGICS MARKET SIZE, BY THERAPEUTIC, BY STATE, 2018-2026 (USD BILLION)
TABLE 12. UNITED STATES BIOLOGICS MARKET SIZE, BY DIRECT MAB AGENTS, BY STATE, 2018-2026 (USD BILLION)
TABLE 13. UNITED STATES BIOLOGICS MARKET SIZE, BY TARGETING MAB AGENTS, BY STATE, 2018-2026 (USD BILLION)
TABLE 14. UNITED STATES BIOLOGICS MARKET SIZE, BY RECOMBINANT HORMONES/PROTEINS, BY STATE, 2018-2026 (USD BILLION)
TABLE 15. UNITED STATES BIOLOGICS MARKET SIZE, BY VACCINES, BY STATE, 2018-2026 (USD BILLION)
TABLE 16. UNITED STATES BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 17. UNITED STATES BIOLOGICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY STATE, 2018-2026 (USD BILLION)
TABLE 18. UNITED STATES BIOLOGICS MARKET SIZE, BY CANCER, BY STATE, 2018-2026 (USD BILLION)
TABLE 19. UNITED STATES BIOLOGICS MARKET SIZE, BY INFECTIOUS DISEASES, BY STATE, 2018-2026 (USD BILLION)
TABLE 20. UNITED STATES BIOLOGICS MARKET SIZE, BY RARE DISEASES, BY STATE, 2018-2026 (USD BILLION)
TABLE 21. UNITED STATES BIOLOGICS MARKET: SCORES
TABLE 22. UNITED STATES BIOLOGICS MARKET: BUSINESS STRATEGY
TABLE 23. UNITED STATES BIOLOGICS MARKET: PRODUCT SATISFACTION
TABLE 24. UNITED STATES BIOLOGICS MARKET: RANKING
TABLE 25. UNITED STATES BIOLOGICS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 26. UNITED STATES BIOLOGICS MARKET: MERGER & ACQUISITION
TABLE 27. UNITED STATES BIOLOGICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 28. UNITED STATES BIOLOGICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 29. UNITED STATES BIOLOGICS MARKET: INVESTMENT & FUNDING
TABLE 30. UNITED STATES BIOLOGICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 31. UNITED STATES BIOLOGICS MARKET: LICENSE & PRICING

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook